Clinica Baviera (XMAD:CBAV) Gross Margin %: 0.00% (As of Mar. 2026)


XMAD:CBAV Clinica Baviera SA XMAD:CBAV
99 GF Score
Price €55.20
GF Value €41.30
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Clinica Baviera Gross Margin %?

Clinica Baviera XMAD:CBAV -0.36% 99 Gross Margin % is 0.00% as of Mar. 2026. GuruFocus rates XMAD:CBAV with a GF Score™ of 99/100 and a GF Value™ of €41.30 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, Clinica Baviera ranks worse than 515463.4% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. Clinica Baviera's Gross Profit for the three months ended in Mar. 2026 was €87.0 Mil. Clinica Baviera's Revenue for the three months ended in Mar. 2026 was €87.0 Mil. Therefore, Clinica Baviera's Gross Margin % for the quarter that ended in Mar. 2026 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Clinica Baviera's Gross Margin % or its related term are showing as below:


During the past 13 years, the highest Gross Margin % of Clinica Baviera was 88.74%. The lowest was 87.14%. And the median was 88.08%.

XMAD:CBAV's Gross Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 50.45
* Ranked among companies with meaningful Gross Margin % only.

Clinica Baviera had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Clinica Baviera was 0.30% per year.


Clinica Baviera  (XMAD:CBAV) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Clinica Baviera had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Clinica Baviera Gross Margin % Related Terms


Clinica Baviera Gross Margin % Historical Data

* Premium members only.

The historical data trend for Clinica Baviera's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinica Baviera Gross Margin % Chart

Clinica Baviera Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 87.56 87.15 87.96 88.36 88.74

Clinica Baviera Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XMAD:CBAV vs TMO, DHR, IDXX: Gross Margin % Comparison

For the Diagnostics & Research subindustry, Clinica Baviera's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clinica Baviera Gross Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clinica Baviera's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Clinica Baviera's Gross Margin % falls into.


XMAD:CBAV
99GF Score
Clinica Baviera SA XMAD:CBAV
Gross Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clinica Baviera Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Clinica Baviera's Gross Margin for the fiscal year that ended in Dec. 2025 is calculated as

Gross Margin % (A: Dec. 2025 )=Gross Profit (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=267.8 / 301.782
=(Revenue - Cost of Goods Sold) / Revenue
=(301.782 - 33.975) / 301.782
=88.74 %

Clinica Baviera's Gross Margin for the quarter that ended in Mar. 2026 is calculated as


Gross Margin % (Q: Mar. 2026 )=Gross Profit (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=87 / 86.974
=(Revenue - Cost of Goods Sold) / Revenue
=(86.974 - 0) / 86.974
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 0.00% mean?
Clinica Baviera (XMAD:CBAV) has a Gross Margin % of 0.00% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Clinica Baviera and its competitors. Over the past decade, Clinica Baviera's Gross Margin % has ranged from 87.14 to 88.74. According to the industry distribution chart, Clinica Baviera ranks #999999 out of 194 companies in the Medical Diagnostics & Research industry.
Is Clinica Baviera's Gross Margin % too high?
Clinica Baviera's current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 87.14 to a high of 88.74. Based on the distribution chart, Clinica Baviera ranks #999999 out of 194 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Clinica Baviera has a GF Score™ of 99/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clinica Baviera's Gross Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Clinica Baviera ranks #999999 out of 194 companies for Gross Margin %. This places Clinica Baviera in the lower half of its industry. The industry median Gross Margin % is 50.45. Historically, Clinica Baviera's own Gross Margin % has ranged from 87.14 to 88.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 50.45, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Clinica Baviera and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 50.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clinica Baviera's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinica Baviera stock overvalued right now?
Based on GuruFocus' analysis, Clinica Baviera (XMAD:CBAV) is currently considered Significantly Overvalued. The stock's GF Value™ is €41.30, compared to a current price of €55.20 — trading 33.7% above its estimated fair value. The current Gross Margin % is 0.00%. Clinica Baviera's overall GF Score™ is 99/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Clinica Baviera (XMAD:CBAV), the current Gross Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clinica Baviera (XMAD:CBAV) Overvalued in 2026?

Based on GuruFocus' analysis, Clinica Baviera stock appears to be overvalued. The current stock price of €55.20 is trading 33.7% above its estimated GF Value™ of €41.30. GuruFocus considers Clinica Baviera to be Significantly Overvalued.

Key valuation signals for XMAD:CBAV:

  • Gross Margin %: 0.00%
  • GF Value™: €41.30 vs. price of €55.20 (33.7% above fair value)
  • GF Score™: 99/100 with 4 warning signs

No single metric tells the full story. See the XMAD:CBAV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clinica Baviera Business Description

Other Exchanges 0GWJ:UKD9Z:Germany
Address Paseo de la Castellana 20, Madrid, ESP, 28046
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
99GF Score

Get the complete analysis for XMAD:CBAV

Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€55.20
Price
€41.30
GF Value